HomeInsightsStock Comparison

Lupin Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Lupin Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Last Updated on: Aug 13, 2025

Key Highlights

  • The Latest Trading Price of Lupin Ltd is ₹ 1943 as of 12 Aug 15:30.
  • The P/E Ratio of Lupin Ltd changed from 38.1 on March 2021 to 28.2 on March 2025 . This represents a CAGR of -5.84% over 5 yearsThe P/E Ratio of Torrent Pharmaceuticals Ltd changed from 32.6 on March 2020 to 57.3 on March 2025 . This represents a CAGR of 9.86% over 6 years.
  • The Market Cap of Lupin Ltd changed from ₹ 26713 crore on March 2020 to ₹ 92522 crore on March 2025 . This represents a CAGR of 23.00% over 6 yearsThe Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 33361 crore on March 2020 to ₹ 109468 crore on March 2025 . This represents a CAGR of 21.90% over 6 years.
  • The revenue of Lupin Ltd for the Jun '25 is ₹ 6347 crore as compare to the Mar '25 revenue of ₹ 5724 crore. This represent the growth of 10.89% The revenue of Torrent Pharmaceuticals Ltd for the Jun '25 is ₹ 3141 crore as compare to the Mar '25 revenue of ₹ 2941 crore. This represent the growth of 6.8%.
  • The ebitda of Lupin Ltd for the Jun '25 is ₹ 1806 crore as compare to the Mar '25 ebitda of ₹ 1378 crore. This represent the growth of 31.07% The ebitda of Torrent Pharmaceuticals Ltd for the Jun '25 is ₹ 995 crore as compare to the Mar '25 ebitda of ₹ 922 crore. This represent the growth of 7.92%.
  • The net profit of Lupin Ltd changed from ₹ 453.33 crore to ₹ 1221 crore over 9 quarters. This represents a CAGR of 55.35% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 378 crore to ₹ 548 crore over 9 quarters. This represents a CAGR of 17.95% .
  • The Dividend Payout of Lupin Ltd changed from 37.36 % on March 2020 to 13.79 % on March 2025 . This represents a CAGR of -15.30% over 6 yearsThe Dividend Payout of Torrent Pharmaceuticals Ltd changed from 57.71 % on March 2020 to 10.76 % on March 2025 . This represents a CAGR of -24.42% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Lupin Ltd

  • Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
  • The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments. Lupin Limited was incorporated in the year 1983 with the name Lupin Chemicals Limited.
  • In March 2001, Lupin Laboratories Limited was amalgamated with the company and the name was changed to Lupin Limited.
  • In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar.

About Torrent Pharmaceuticals Ltd

  • Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
  • The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
  • The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
  • It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 12 countries with major setups in the US, Germany and Brazil.

Lupin Ltd News Hub

News

Lupin partners with Sandoz for launch and commercialization of ranibizumab across global markets

Lupin today announced that it has partnered with Sandoz Group AG (Sandoz), Switzerland, to...

Read more

12 Aug 2025 11:23

News

Lupin joins hands with Sandoz to commercialize biosimilar Ranibizumab across multiple regions

Under the agreement, Sandoz will handle commercialization of the biosimilar across the Eur...

Read more

12 Aug 2025 14:31

News

Lupin gains after launching Glucagon for Injection in U.S. market

The product is bioequivalent to Eli Lilly and company's Glucagon for Injection, 1 mg/vial,...

Read more

11 Aug 2025 11:04

News

Lupin launches Glucagon for Injection USP, 1mg/vial in US market

Lupin today announced the launch of Glucagon for Injection USP, 1mg/vial packaged in an em...

Read more

11 Aug 2025 16:20

News

Lupin Q1 PAT climbs 52% YoY to Rs 1,219 cr in FY26

Profit before tax (PBT) rose 42.55% YoY to Rs 1415.54 crore in Q1 FY26. EBITDA stood at Rs...

Read more

06 Aug 2025 10:56

News

Lupin Ltd gains for fifth session

Lupin Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 1975.9, ...

Read more

29 Jul 2025 13:00

Torrent Pharmaceuticals Ltd News Hub

News

Torrent Pharma's Vizag facility clears USFDA inspection with zero observations

According to an exchange filing, the inspection was conducted from 28 July to 1 August 202...

Read more

04 Aug 2025 09:44

News

Torrent Pharma gains as Q1 earnings impress; foreign broker hikes target

The pharma major reported a net profit of Rs 548 crore, marking a 20% year-on-year increas...

Read more

29 Jul 2025 10:36

News

Torrent Pharmaceuticals Ltd gains for third straight session

Torrent Pharmaceuticals Ltd is up for a third straight session today. The stock is quoting...

Read more

29 Jul 2025 13:05

News

Board of Torrent Pharmaceuticals approves issuance of NCDs/ bonds

The Board of Torrent Pharmaceuticals at its meeting held on 28 July 2025 has approved the ...

Read more

28 Jul 2025 16:32

News

Torrent Pharmaceuticals to hold board meeting

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28...

Read more

22 Jul 2025 10:21

News

Torrent Pharmaceuticals Ltd gains for fifth session

Torrent Pharmaceuticals Ltd is up for a fifth straight session in a row. The stock is quot...

Read more

18 Jul 2025 13:00

SWOT Analysis Of Torrent Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Lupin Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Torrent Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Lupin Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Lupin Ltd and Torrent Pharmaceuticals Ltd

Which company has a larger market capitalization, Lupin Ltd or Torrent Pharmaceuticals Ltd?

Market cap of Lupin Ltd is 88,782 Cr while Market cap of Torrent Pharmaceuticals Ltd is 122,787 Cr

What are the key factors driving the stock performance of Lupin Ltd and Torrent Pharmaceuticals Ltd?

The stock performance of Lupin Ltd and Torrent Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lupin Ltd and Torrent Pharmaceuticals Ltd?

As of August 13, 2025, the Lupin Ltd stock price is INR ₹1943.8. On the other hand, Torrent Pharmaceuticals Ltd stock price is INR ₹3628.15.

How do dividend payouts of Lupin Ltd and Torrent Pharmaceuticals Ltd compare?

To compare the dividend payouts of Lupin Ltd and Torrent Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions